Type 1 regulatory T cells (Tr1 cells) are induced by interleukin-27 (IL-27) and have critical roles in the control of autoimmunity and resolution of inflammation. We found that the transcription factors IRF1 and BATF were induced early on after treatment with IL-27 and were required for the differentiation and function of Tr1 cells in vitro and in vivo. Epigenetic and transcriptional analyses revealed that both transcription factors influenced chromatin accessibility and expression of the genes required for Tr1 cell function. IRF1 and BATF deficiencies uniquely altered the chromatin landscape, suggesting that these factors serve a pioneering function during Tr1 cell differentiation.
IL-10-producing Tr1 cells were first described as a distinct subset of T cells that are induced in vitro by activating naive T cells in the presence of IL-10 (ref. 1). They produce copious amounts of IL-10, their signature cytokine, but do not express Foxp3, the key transcription factor for differentiation of regulatory T (T reg ) cells. Tr1 cells' strong immunosuppressive capacity allows them to restrain autoimmune responses and alleviate pathology in models of autoimmune disease [2] [3] [4] . IL-27 suppresses Foxp3 expression, but induces differentiation of Tr1 cells in vitro and in vivo [5] [6] [7] . Il27ra −/− mice lack Tr1 cells, have an increased number of T H 17 cells, both in the periphery and in the central nervous system, and, as a result, develop more severe experimental autoimmune encephalomyelitis (EAE) 8 .
IL-27 receptor signaling induces expression of the transcription factor c-Maf and the ligand-activated transcription factor aryl hydrocarbon receptor (AhR), which physically associate during Tr1 induction and together bind to and transactivate the Il10 and Il21 promoters 9 . IL-21 acts as an autocrine growth factor for Tr1 cells 10 . IL-27 induces early growth response gene 2 (Egr-2), which controls Blimp1-mediated IL-10 upregulation through direct activation of the Prdm1 promoter 11 . Thus, IL-27 induces transcription factors that regulate IL-10 production, but it is unclear whether it also regulates the chromatin landscape and access of transcription factors to key target genes.
During CD4 + T cell differentiation, in addition to the 'master regulator' transcription factors, a set of 'pioneering factors' are induced that shape the epigenetic landscape in differentiating T cells and regulate accessibility of transcriptional regulators to lineage specific genomic elements [12] [13] [14] . BATF and IRF4 were recently shown to regulate chromatin accessibility and exhibit pioneer-like functions during differentiation of T H 17 (ref. 15 ) and CD8 + T cells 16 . We found that BATF and IRF1 were induced early on during Tr1 differentiation and act as pioneering factors for differentiation of Tr1 cells.
RESULTS

IRF1 and BATF control Tr1 differentiation in vitro
We analyzed global gene expression following engagement of the TCR on naive CD4 + T cells cultured in the presence (Tr1) or absence (T H 0) of IL-27. Analysis at 2 h placed IRF1 and BATF among the highest ranked putative transcription factors that were crucial for the regulation of Tr1 differentiation (Fig. 1a) . Using quantitative PCR (qPCR), we found two waves of Irf1 expression, peaking at around 3-6 h and 12-15 h after activation in the presence of IL-27, and two waves of Batf expression, peaking at roughly 1 and 24 h (Fig. 1b) . We activated naive CD4 + T cells from Irf1 −/− and Batf −/− mice in the presence of IL-27 and analyzed T cell differentiation 72 h later. Both Irf1 −/− (Fig. 1c,d ) and Batf −/− (Fig. 1e,f ) cells failed to produce IL-10 (mRNA and protein) or differentiate into Tr1 cells and expressed decreased levels of interferon-γ (IFN-γ; Fig. 1c,e) .
Although there was a decrease in the percentage of total IFN-γ + cells and IFN-γ + IL-10 + cells in Batf −/− cells treated with IL-27, the frequency of IFN-γ + IL-10 − cells remained unchanged in the Batf −/− cells (Supplementary Fig. 1a ). This may reflect the role of BATF in T H 1 cells, as IL-27 regulates T H 1 differentiation 17 . In contrast with Tr1 cells, we found enhanced differentiation of both Irf1 −/− and Batf −/− cells into Foxp3 + T reg cells (Supplementary Fig. 1b) . Thus, IRF1 and BATF are indispensable for generation of IL-27-induced Tr1 cells in vitro.
The effects of IRF1 and BATF deficiency on Tr1 function IL-27 treatment activates phosphorylation of STAT1 and STAT3, both of which are required for Tr1 differentiation 18 . We found that Irf1 expression was dependent on STAT1, but independent of STAT3 ( Fig. 2a) . In contrast, Batf expression was reduced in Stat3 −/− cells, but remained unchanged in Stat1 −/− cells (Fig. 2b) .
Overexpression of IRF1, but not BATF, enhanced Il10 expression in IL-27-treated cells (Fig. 2c) , although concurrent overexpression of IRF1 and BATF did not induce Il10 expression ( Supplementary  Fig. 1c ). BATF overexpression strongly induced Maf and Il21 in Tr1 conditions, whereas both IRF1 and BATF augmented Ahr expression in cells treated with IL-27. These results suggest that IRF1 and BATF have separate roles in Tr1 differentiation.
IRF1 affects induction and resolution of autoimmune disease
We induced EAE in Irf1 −/− mice to assess the role of IRF1 in autoimmunity. In contrast with wild-type mice, in which clinical scores peaked and diminished over time, Irf1 −/− mice developed progressively more severe disease (Fig. 3a) .
We found an increased percentage CD4 + T cells expressed IL-17A and IFN-γ, with the most prominent change occurring in the frequency of double cytokine-producing cells (IL-17A + IFN-γ + ) in the central nervous system of Irf1 −/− mice (Fig. 3b,c) . Transfer of CD4 + T cells from wild-type or Irf1 −/− mice into Rag2 −/− mice and induction of EAE in the recipients resulted in increased disease scores in recipients of the Irf1 −/− CD4 + T cells (Fig. 3d) . In addition, we crossed IRF1-deficient mice to TCR transgenic 2D2 mice 19 specific for MOG (Irf1 −/− 2D2).
A small fraction (about 6%) of 2D2 transgenic mice generally develop spontaneous EAE; however, all of the Irf1 −/− 2D2 mice developed spontaneous EAE (Fig. 3e) , supporting a direct role for IRF1 in the regulation of CD4 + T cell responses in disease.
Proliferation of CD4 + lymphocytes isolated from the spleen and draining lymph nodes of MOG -immunized Irf1 −/− mice was strongly enhanced (Fig. 3f) . Furthermore, these cells secreted more IL-17A and IFN-γ following restimulation with MOG both in the presence or absence of IL-23 ( Fig. 3g,h) Fig. 1d) .
Batf −/− mice are resistant to EAE 20 , and Batf −/− T cells failed to develop a T H 17 gene signature given the requirement of BATF as a pioneering factor (Supplementary Fig. 1d ). Irf1 −/− CD4 + T cells primed in vitro in T H 17 conditions produced increased levels of IL-17A (Supplementary Fig. 1e,f) . Taken together, our results indicate that IRF1 deficiency promotes generation of T H 17 cells in vivo and impairs resolution of autoimmunity in EAE .
IRF1 and BATF control generation of IL-10 + Tr1 cells in vivo
To determine whether IRF1 deficiency can affect IL-10 in lymphocytes during autoimmune inflammation, we induced EAE in wild-type and Irf1 −/− mice and isolated CD4 + T cells from the draining lymph nodes and the central nervous system at the beginning of the resolution of clinical disease (day 19). We found decreased amounts of Il10 mRNA in both the central nervous system and the draining lymph nodes of Irf1 −/− animals (Fig. 4a) .
We immunized wild-type mice with MOG and analyzed CD4 + T cells that reactivated in vitro in the presence of the MOG 35- A r t i c l e s downregulated 13 (>2-fold decrease) when compared with cultures activated without IL-27 ( Fig. 4b) , consistent with gene expression changes observed in vitro (Supplementary Fig. 1g) (Fig. 4d) . Consistent with these data, repeated administration of anti-CD3 antibody, which induces IL-10 in the mesenteric lymph nodes of wild-type C57/BL6 mice, failed to induce IL-10 in Irf1 −/− or Batf −/− mice (Fig. 4e) . Furthermore, splenocytes from these mice failed to produce IL-10 following restimulation (Fig. 4f) . Thus, we conclude that both IRF1 and BATF control generation of Tr1 cells in vivo.
IRF1 and BATF control the Il10 locus
To test whether IRF1 and BATF can interact with the Il10 promoter in CD4 + T cells, we differentiated wild-type naive CD4 + T cells for 72 h in the presence of IL-27 and performed chromatin immunoprecipitation (ChIP) using antibodies against IRF1 and BATF, followed by qPCR. We used probes spanning previously described conserved non-coding sequences (CNS) and hypersensitivity (HSS) sites in the Il10 locus 21, 22 (Fig. 5a) . We detected IRF1 binding to the CNS-9, HSS-0.12 and HSS + 2.98 sites (Fig. 5b) , with HSS-0.12 containing two putative IRF1-binding sites 23 (designated as HSS-0.12 site1 and site2).
ChIP also revealed two BATF-binding sites, at the CNS-9 and HSS + 2.98 sites of the Il10 locus (Fig. 5c) . Given that we observed some overlap between the IRF1 and BATF binding sites in the Il10 locus, we tested the degree of co-occupancy of IRF1 and BATF using a sequential ChIP assay (ReChIP). We found a nearly complete (around 90%) co-occupancy of IRF1 and BATF at the CNS-9 site and a strong co-occupancy (around 60%) at the HSS + 2.98 site (Fig. 5d) . To evaluate a regulatory interaction between these two transcription factors, we performed ChIP for BATF in Irf1 −/− and for IRF1 in Batf −/− Tr1-polarized cells. Binding of IRF1 and BATF in the Il10 locus was markedly reduced in Batf −/− and Irf1 −/− cells, respectively (Fig. 5e,f) .
As BATF and IRF4 exhibit a similar dependency in T H 17 cells, we investigated potential competition for binding between IRF1 and IRF4 (refs. 24,25) . Tr1 cells that were differentiated from Irf4 −/− cells expressed increased amounts of IL-10 ( Supplementary Fig. 2a ) compared with wild-type cells, which is in contrast to Irf1 −/− cells. Furthermore, overexpression of IRF1 antagonized IRF4-induced expression from an IL-17A reporter and IRF4 antagonized IRF1-induced expression from an IL-10 reporter in 293T cells ( Supplementary Fig. 2b-e) . We investigated binding of IRF1 to the IRF4 genomic binding sites on T H 17-associated (Il17a, Il23r and Rorc) loci and found strongly increased IRF1 binding in IRF4-deficient T H 17-polarized cells (Supplementary Fig. 2f ).
We analyzed whether IRF1 or BATF deficiency could affect the distribution of epigenetic marks in the Il10 locus in Tr1-polarized cells. We performed ChIP-qPCR assay in Tr1-primed cells with antibodies directed against H3K9Ac, H3K4me3 and H3K27me3. We found decreased recruitment of activating marks (H3K9Ac, H3K4me3) in the absence of both IRF1 and BATF, as well as increased repressive marks (H3K27me3) in cells from both knockouts (Fig. 5g) . These results point to the role of both transcription factors in the induction of epigenetic changes during Tr1 differentiation, and possibly reveal one of the mechanisms by which IRF1 and BATF factors induce IL-10 following priming with IL-27. . ns, not significant (P > 0.05); *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 (unpaired t test, error bars represent mean ± s.e.m.).
A r t i c l e s
Differential effects of IRF1 and BATF on the Il10 promoter To investigate whether IRF1 and BATF can directly transactivate the Il10 promoter, we used reporter constructs driven by either the proximal Il10 promoter (−1.5 kb) containing the HSS-0.12 site or by the CNS-9 or HSS + 2.98 regions cloned upstream of the Il10 minimal promoter. c-Maf transactivation of the Il10 proximal promoter was used as a control. IRF1 directly transactivated the Il10 proximal promoter, and coexpression of IRF1 and c-Maf had an additive effect (Fig. 6a) . Furthermore, IRF1 strongly transactivated expression regulated by the CNS-9 and HSS + 2.98 regions of Il10, whereas BATF had no effect in transactivation of these constructs (Fig. 6b) .
Overexpression of c-Maf in T H 0 cells induces IL-10 expression even without IL-27. We hypothesized that, in physiological conditions, this effect might depend on IRF1. We overexpressed c-Maf in wild-type and Irf1 −/− CD4 + T cells; c-Maf was unable to fully induce IL-10 in Irf1 −/− cells (Fig. 6c) , indicating that c-Maf might not be able to bind to and/or transactivate the Il10 locus in the absence of IRF1. Although BATF is required for c-Maf expression 26 , overexpression of c-Maf failed to rescue the phenotype of Batf −/− cells that were polarized in Tr1 conditions (Fig. 6d) .
We then directly analyzed whether binding of c-Maf to the Il10 locus is altered in Irf1 −/− cells. We performed ChIP with differentiated wild-type or Irf1 −/− Tr1-polarized cells and looked at known c-Maf binding sites in the Il10 locus (MARE-1-4). We found that c-Maf binding was significantly reduced in Irf1 −/− cells (Fig. 6e) .
In parallel, we analyzed whether BATF deficiency affects binding of other transcription factors known to bind to the Il10 locus. Given that Batf −/− cells do not express c-Maf, we investigated binding of AhR to the XRE1 site, as AhR is known to bind to and transactivate this site in Tr1-polarized cells. We found that AhR failed to localize to its putative binding site in both Irf1 −/− and Batf −/− Tr1-polarized cells (Fig. 6f) . Collectively, these results indicate that both IRF1 and BATF might induce chromatin changes that allow additional transcription factors to bind to and transactivate the Il10 locus, suggesting a possible pioneer role in Tr1 cells for one or both of these factors.
BATF and IRF1 deficiencies alter the Tr1 chromatin landscape
To assess potential pioneering roles of BATF and IRF1 during Tr1 differentiation, we measured chromatin accessibility using ATAC-seq (assay for transposase accessible chromatin using sequencing) in Tr1 , and a late time point, 72 h. We detected ~180,000 accessible regions (peaks) across samples, and the data quality enabled quantitative analysis of peak intensities across sample conditions (Fig. 7a-c and Supplementary Fig. 3a) . Time, polarization condition and BATF deficiency had the most notable effects on the chromatin landscape, with each perturbation leading to upwards of 20,000 altered accessible regions (false discover rate (FDR) = 10%, log 2 |fold-change| > 1; Supplementary Fig. 3a) .
To globally relate chromatin accessibility patterns across samples, we performed principal component analysis (PCA) (Supplementary  Fig. 3b) . At 24 h, all samples displayed relatively similar chromatin landscapes, although we observed small differences between Tr1 and T H 0 polarizations for Batf −/− , Irf1 −/− and control cells. At 72 h, the T H 0-versus Tr1-dependent trends dominated; however, the Batf −/− chromatin landscape resembled neither Tr1 nor T H 0. At 72 h (Fig. 7b) , Batf −/− T H 0 and Tr1 cells had a distinct chromatin accessibility pattern, whereas Tr1 cells derived from mice deficient in IRF1, AhR and c-Maf showed relatively similar chromatin accessibility patterns. These analyses provide high-level support for BATF as a pioneering factor in Tr1 cells, consistent with its role in T H 17 and CD8 + T cells 15, 16 .
To address a potential pioneering role for IRF1, we performed differential analysis with DESeq2 to quantify the number of transcription-factor-dependent accessible peaks per transcription factor in Tr1 conditions (Fig. 7c) , subsampling to ensure equal statistical power for each knockout condition. In this controlled analysis, BATF deficiency led to altered accessibility (log2(|fold-change|) > 1, FDR = 10%) at over 20,000 loci (10,000 increased and 10,000 decreased). IRF1 deficiency resulted in ~100 peaks with increased accessibility and 1,100 peaks with decreased accessibility. In contrast, AhR-and c-Maf-dependent alterations were minor, consistent with a heat map that we generated in which BATF-and IRF1-dependent decreases in accessibility were apparent. Notably, each factor appeared to affect unique regions. In addition, BATF-dependent chromatin regions with increased accessibility were visible in Batf −/− cells, suggesting that, although much of the Tr1 landscape is being 'turned off ' , new regions are also being 'turned on' .
Although the scale of IRF1-and BATF-dependent changes differed, both transcription factors altered chromatin accessibility, whereas cMaf and AhR did not. This finding, combined with our data showing Fig. 4a ).
In agreement with the ATAC-seq analysis, BATF deficiency led to the greatest number of differentially expressed genes (~500 genes, compared with ~110 for Irf1 −/− ; Supplementary Fig. 4b,c) . IRF1 and BATF deficiency resulted in large differences in transcription factor expression profiles (Fig. 7d) (Fig. 7e) .
We integrated the ATAC-seq and RNA-seq data sets to derive transcriptional regulatory networks for both IRF1-and BATF-deficient Tr1 cells. We integrated our quantitative ATAC-seq and RNA-seq information to find transcription factors that showed concurrent changes in expression and motif-containing peak accessibility. The relative perturbation strengths of IRF1 versus BATF deficiencies were reflected in the scale of the resulting transcriptional regulatory networks. The changes induced by IRF1 deficiency were relatively limited ( Fig. 7f and Supplementary Fig. 5 ). IRF1 putatively repressed Klf7, as Klf7 was overexpressed in Irf1 −/− cells and an accessible IRF1 motif was found cis to the Klf7 locus. The KLF7 motif, in turn, was enriched cis to genes with increased expression under IRF1-deficient conditions, such as Id3 (Fig. 7g) . STAT1 was also IRF1 dependent, with an accessible IRF1 motif in cis, but STAT1 was a part of the Tr1 network that turned off in Irf1 −/− cells (Ccl4, Il13ra1, Ccl3, Il10 and Zbp1; Fig. 7g ). IRF1 might also directly regulate expression of a number of genes, such as Il10, Ccr5 and Prf1 (Fig. 7g) .
The BATF Tr1 network is more complex, involving 16 transcription factors (Fig. 7h,i) . Explanations for the part of the Tr1 BATF network that is turned on can only be explained indirectly, by several transcription factors regulated downstream of BATF. The part of the Tr1 network that is turned off is explained not only by potentially direct BATF targets, but also likely involves secondary regulatory interactions mediated by c-Maf, HIF1A, FOSL2, ETS1, RUNX2, KLF10, RORG and RORA (Supplementary Fig. 6 ). BATF induced expression of Klf10, Runx2, Prdm1, Hif1a, Fols2 and Ets1, whose expression was reduced in the Batf −/− cells (Fig. 7i) . They, in turn, might regulate a number of other cytokines or receptors that we found to be differentially expressed in the Batf −/− T cells, such as Il10, Prf1, Icos, Il2, Csf2, Cxcr5, and Il1rn. The 'off ' network was connected to the 'on' network by RUNX2 and KLF10, which putatively repress the on transcription factors Eomes, Csr2 and Sp6, and several members of the NF-κB family. The Batf −/− Tr1 transcriptional regulatory model suggests a markedly altered transcriptional state for BATFdeficient Tr1 cells, mediated by several layers of altered transcriptional regulatory interactions.
DISCUSSION
Although IL-10-producing Foxp3 − Tr1 cells are critical for regulation of autoimmunity, the Tr1 lineage-defining factors or the pioneering factors that set up the genomic landscape for Tr1 differentiation have not yet been defined. The greatest extent of transcriptome remodeling occurs during the early phases of T cell activation, before lineagedefining transcription factors are induced. To identify pioneering factors for Tr1 differentiation, we analyzed an early time point following IL-27 priming to uncover the transcription factors that potentially establish a 'Tr1 epigenetic landscape' . IRF1 and BATF were strongly induced at 2h following TCR activation and priming with IL-27. Both factors were indispensable for induction of Tr1 cells in vitro as well as for generation of Tr1 cells and protection from autoimmune disease in vivo. ; n = 3 samples) or pooled from two independent experiments (e,f). Dots represent technical replicates (a-d) or biological replicates (e,f). NS, not significant (P > 0.05); *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.
During activation with IL-27, Tr1 cells activate both STAT-1 and STAT-3 to induce IL-10 production and develop a Tr1 transcriptional program. Previous studies have suggested that IL-27-induced STAT1 and STAT3 make distinct contributions to the transcriptional output. Although STAT3 deficiency is associated with a loss of the overall cytokine response, the major function of STAT1 is to provide specificity 27 . We found that IRF1 was expressed downstream of STAT1, whereas BATF expression was STAT3 dependent, which might A r t i c l e s account for some of the transcriptional differences observed between STAT1 and STAT3 deficiency. Cooperative binding between BATF and IRF4 alters initial chromatin accessibility and thus pioneer access of transcription factors that specify the T H 17 developmental program 15 . AP-1 and IRF complexes also cooperatively promote transcription of the Il10 gene in T H 17 cells 28 . IRF1 and BATF binding sites colocalized at two locations in the IL-10 promoter, and cooperative binding between them in Tr1 cells was supported by our findings that IRF1 and BATF occupancy in the Il10 locus was markedly reduced in BATF-and IRF1-deficient cells, respectively.
Our results indicate that, although BATF is required for the differentiation of both T H 17 and Tr1 cells, IRF4 and IRF1 are differentially required for the differentiation of these T cell subsets, and therefore provide specificity in the regulation of the genomic landscape for T H 17 versus Tr1 differentiation. Preferential binding of IRF1 to shared interferon-stimulated response element sites would limit accessibility of IRF4 and inhibit T H 17 differentiation, whereas loss of IRF1 would inhibit Tr1 differentiation and promote unopposed binding of IRF4 and subsequent T H 17 differentiation, consistent with our data. These opposing effects of IRF1 on Tr1 and T H 17 cell differentiation suggest that IRF1 might regulate the balance between the two cell subsets and act as a molecular switch between the regulatory Tr1 cells and the pathogenic T H 17 cells. Consequently, both an increase in T H 17 cell differentiation and a decrease in Tr1 generation could contribute to the increased susceptibility of Irf1 −/− mice to EAE.
Our data suggest that IRF1 and BATF are critical for preparing the chromatin landscape during Tr1 differentiation and may serve as pioneer factors for the Tr1 lineage. Indeed, our chromatin accessibility patterns data suggest that BATF and IRF1 prepare chromatin as crucial early mediators of IL-27-driven Tr1-specific transcription. Although smaller in scale than BATF deficiency, IRF1 deficiency altered a unique set of accessible regions, and both transcription factors increased chromatin accessibility and facilitated binding of other transcription factors to the chromatin. Therefore, we propose that IRF1 is a "small-scale" pioneer factor affecting some chromatin regions that are indispensable for Tr1 differentiation. In contrast, BATF, which serves as a pioneer factor for a number of other cell types 15, 16 , affected the chromatin landscape in undifferentiated T H 0 cells and had global effects on Tr1 differentiation. This suggests a general role for BATF as a pioneering factor for T helper cell differentiation. Integration of RNA-seq and ATAC-seq indicates that the BATF-dependent network consists of several layers of transcriptional interactions and that loss of BATF completely alters the IL-27-induced transcriptional state. Importantly, BATF appears to regulate Il10 induction indirectly. The IRF1-dependent network is smaller, yet, IRF1 can regulate Tr1 differentiation both directly (through direct interaction of IRF1 with Il10, Prf1) and indirectly (through Stat1 and Klf7).
Our studies uncovered the critical role of two transcription factors, IRF1 and BATF, in preparing the chromatin landscape for induction of the Tr1 gene network in response to IL-27 signaling, where BATF acted as a pioneer factor and prepared the genomic landscape for the binding of additional transcription factors that define the Tr1 lineage. IRF1 specifically transactivated Il10 gene expression and a smaller cluster of genes that characterized the Tr1 lineage while restraining T H 17 differentiation. Together, these data define BATF and IRF1 as drivers of the earliest steps in the induction of the Tr1 lineage.
METhODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
NanoString gene expression analysis. Sorted CD4 + T cells were lysed using RLT buffer (Qiagen) and hybridized with a custom made CodeSet according to the manufacturer's instructions. Barcodes were counted (1,150 field of view sample) on an nCounter Digital Analyzer following manufacturer's protocol (NanoString Technologies Inc.). Data were analyzed using nSolver Analysis Software.
In vivo treatment with anti-CD3. Wild-type, Irf1 −/− or Batf −/− mice were treated with 20 µg of antibody targeted against CD3 (clone 2C11) or an isotype control administered i.p. every 3d for a total of three times. Mice were sacrificed 4 h after the last treatment. Il10 expression in the mesentheric lymph nodes was analyzed by intracellular staining.
Statistical analysis. Statistical analysis was performed using Prism software (Graph Pad software). Linear regression with a 95% confidence interval, and unpaired, two-tailed Student's t test were used for comparison of two groups. P values<0.05 were considered significant. ATAC-seq. Samples were prepared as described previously 32 . Paired-end 50-bp sequences were generated from samples on an Illumina HiSeq2500. Sequences were mapped to the murine genome (mm9) with bowtie2 (2.2.3) (ref. 33) , filtered based on mapping score (MAPQ > = 30, Samtools (0.1.19)), and duplicates removed (Picard). We then identify peak-centered, accessible regions across all samples. For each sample individually, we ran Peakdeck 34 (parameters −bin 75, -STEP 25, -back 10000, -npBack100000) and filtered peaks with a P raw < 10 −4 . We then limited accessible sequence to the region surrounding peak maxima, using a custom script to find peak maxima and Bedtools 35 (2.17.0) slop function to extend sequence by ±25 bp of the maxima. These peak-centric accessible regions were merged to generate a single reference peak annotation file, and reads per reference peak were counted with HTSeqcount 36 . This pipeline resulted in ~15 million reads per sample, ~30% of which mapped to the 180,478 identified peaks. We used DESeq2 37 to normalize and identify differentially accessible peaks across conditions. Downstream analysis and data visualization were performed in MATLAB R2014B.
RNA-seq. Samples were prepared as described previously 38 and sequenced on Illumina Hi-Seq 2500. Sequences were mapped to the murine genome (mm10) with STAR 39 . DESeq2 was used to normalize and identify differentially expressed transcripts across conditions. Downstream analysis and data visualization were performed in MATLAB R2014B.
Transcriptional regulatory networks.
To define the Tr1 Batf knockout and Irf1 knockout networks, we leveraged the quantitative nature of the ATACseq and RNA-seq data sets. Peaks were associated with putative transcription factor (TF) binding events and target genes using a compendium of human and mouse TF motifs downloaded from the ENCODE motif collection 40 (http://compbio.mit.edu/encode-motifs) and the CisBP motif collection 41 (http://cisbp.ccbr.utoronto.ca). Mouse motifs were also downloaded from the CisBP collection. We scanned peaks for individual motif occurrences with FIMO 42 (parameters-thresh 0.00001,-max-stored-scores 500000, and a first-order background model). In addition to leveraging motifs of human TF orthologs, we increased the mouse TF coverage of our motif database by additionally considering TF family subclasses 43 . We took advantage of similarities among TF subfamily sequence preferences to detect potential binding events of poorly characterized TF subfamily members. Putative binding events were associated with a target gene, if the peak fell within + /-10kb of gene body. We used the knockout RNA-seq data sets and defined potentially direct BATF or IRF1 regulatory interactions if (1) genes were differentially expressed (FDR = 10% and had log 2 |fold-change| >1) and (2) the TF's motif occurred cis to the gene. To extend the networks, we defined sets of differentially expressed genes and tested (hypergeometric distribution, P raw < 10 −3 ) whether differentially expressed transcription factors had motifs enriched cis to a given set of genes, a procedure similar to that described previously 44 .
In addition, we tested for enrichment limited to cis peaks having relevant patterns. For example, to define the BATF-dependent Tr1 network (for example, the part of the network that turns off), we focused on the set of genes with decreased BATF-dependent expression, and searched for enrichment of transcription factors with decreased expression whose motif was either enriched cis when considering (1) all peaks or (2) only peaks that were decreased in accessibility (that is, suggesting a concurrent decrease in binding event). For each knockout Tr1 network, we looked for TF motif enrichment cis to genes increased (decreased) in expression and focusing on all peaks as well as those increased (decreased) in accessibility (suggesting activating interactions), and, to recover both activating and inhibitory interactions, we looked for enrichment cis to all differentially expressed genes. We used correlation between TF and target gene expression to infer interaction sign. Networks were visualized using a newly designed interactive interface 45 , based on iPython 46 and packages: igraph 47 , numpy and scipy 48 . The networks can be downloaded as tab-delimited text files, visualized in iPython notebooks and launched as binders from https://github.com/simonsfoundation/Tr1_batfKO. Data availability. The data that support the findings of this study are available from the corresponding author upon request. Microarray, RNA-seq and ATAC-seq data have been deposited at the Gene Expression Omnibus with accession codes GSE92994 and GSE92940.
